Skip to content
CDMO Services

API Drug Substance Development & Manufacturing

Taking a drug substance from a literature route to a validated process that produces the same material, batch after batch, for years.

Most API programmes do not fail on chemistry. They fail on the gap between a route that works once in a flask and a process that works every time in a six thousand litre reactor, with the impurity profile controlled, the cycle time affordable and the operators safe.

Closing that gap is the work.

What we take on

We work on small-molecule drug substances and their advanced intermediates. Typical engagements start at one of three points:

  • You have a published or patented route and need it made at scale, reliably and at a defensible cost.
  • You have an existing supplier and need a qualified second source with its own dossier.
  • You have a target and no settled route, and need the chemistry worked out from scratch.
What we take on

Controls that run through every stage

Impurity control strategy

Process-related impurities and degradants identified, tracked and controlled to ICH Q3A limits, with genotoxic impurity assessment where the chemistry warrants it.

Process safety

Reaction calorimetry and thermal hazard assessment before any exotherm goes to scale. Scale-up does not proceed on the assumption that it will be fine.

Solvent and waste strategy

Solvent selection reviewed for recoverability and effluent load, because a route that cannot be run cleanly cannot be run cheaply either.

Critical parameter definition

The handful of parameters that actually move the outcome are identified and given proven acceptable ranges, rather than locking down everything indiscriminately.

Polymorph and particle control

Crystallisation developed for consistent form and particle size distribution, which is usually where downstream formulation problems originate.

Dossier-ready records

Development is documented as it happens, in a form that supports a filing. Reconstructing a development history two years later is nobody's idea of a good time.

Speak to someone who knows the answer

Technical, regulatory or commercial - your enquiry reaches a person who works on this, not a shared inbox.

Inquiry Received!

Our sales executive will contact you shortly.